No Data
No Data
Express News | Aptorum Therapeutics Granted U.S. Patent #12023334: Composition Including Rilpivirine And Method For Treating Tumors Or Cancer
Aptorum Group Extends Merger Agreement Term
Express News | Aptorum Group Ltd -Agreed to Extend Date on Which Merger May Be Terminated IF Closing Has Not Occurred From May 30 to Dec 31
Express News | Aptorum Group Ltd -on May 28, Parties to Merger Entered Into That Certain Amendment, to Extend Date on Which Merger May Be Terminated
Express News | Aptorum Group Ltd -on March 6, Entered Into Agreement and Plan of Merger, Dated March 1, With Yoov Group Holding Limited
12 Health Care Stocks Moving In Friday's Intraday Session
No Data
TLOH OP :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)